The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Fact checked by Nick Blackmer Older adults with fluctuating cholesterol levels may have an increased risk of developing ...

Get real-time updates on health from celebrity fitness secrets and weight loss breakthroughs to nutrition advice, get your ...

New research has shown that diet could influence the risk of both depression and Alzheimer's disease (AD). Evidence suggests that depressive symptoms are both a risk factor for AD and a reaction to ...

Met primary endpoint of safety and tolerability in CCM patients with no treatment-related discontinuations or Grade 3 adverse ...

Antibodies.com, a trusted provider of high-quality biological reagents for life science researchers, and Cactus Communications (CACTUS), a global leader in science communication and technology, today ...

Cardiac clearance” can reveal heart issues, reduce surgical risk and even save a life. The evaluation helps ensure your body ...

Findings of a new study suggest that the quality of LDL and HDL cholesterol, rather than their quantity, is more important in ...

Data from a live-fire mortar exercise by U.S. Army troops indicates that simply standing near mortars can significantly ...

Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.

New research from Edith Cowan University (ECU) has shown that diet could influence the risk of both depression and Alzheimer's disease (AD). Evidence ...

Atherosclerosis cardiovascular disease (ASCVD)-related mortality is higher in patients with lupus nephritis (LN) compared ...